ELEVATED BODY MASS INDEX IS NOT ASSOCIATED WITH INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS OR DEATH IN COVID-19 PATIENTS

被引：0
|
作者：
Nguyen, H. [1 ]
Ikram, F. [1 ]
Nguyen, N. [1 ]
Patel, C. [1 ]
Acharya, P. [1 ]
Dhillon, A. [1 ]
Sidhu, M. [1 ]
机构：
[1] Methodist Hlth Syst, Dallas, TX USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2021年 / 69卷 / 02期
关键词：
D O I：
10.1136/jim-2021-SRMC.201
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
201
引用
下载
收藏
页码：497 / 498
页数：2
相关论文
共 50 条
  • [41] Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
    Hifumi, Toru
    Isokawa, Shutaro
    Otani, Norio
    Ishimatsu, Shinichi
    CRITICAL CARE, 2020, 24 (01):
  • [42] Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
    Toru Hifumi
    Shutaro Isokawa
    Norio Otani
    Shinichi Ishimatsu
    Critical Care, 24
  • [43] Elevated serum endocan levels are associated with major adverse cardiovascular events in patients with coronary artery disease
    Sun, Fuqing
    Chen, Yifei
    Lin, Yongfang
    Chen, Ping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C209 - C209
  • [44] Body mass index modifies the major adverse cardiovascular and cerebral events risk of NT-proBNP in patients with acute coronary syndrome
    Xiaoquan He
    Xiaojing Fang
    Jiali Wang
    Shumei Zhao
    Xiaosong Ding
    Hui Chen
    Diabetology & Metabolic Syndrome, 17 (1):
  • [45] COVID-19 vaccination and major cardiovascular and haematological adverse events in Abu Dhabi: retrospective cohort study
    Pimentel, Marco A. F.
    Shaikh, Maaz
    Al Safi, Muna
    Naqvi, Yousuf
    Khan, Shadab
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [46] Higher intraindividual variability of body mass index is associated with elevated risk of COVID-19 related hospitalization and post-COVID conditions
    Yu, Elaine A.
    Bravo, Marjorie D.
    Avelino-Silva, Vivian I.
    Bruhn, Roberta L.
    Busch, Michael P.
    Custer, Brian
    INTERNATIONAL JOURNAL OF OBESITY, 2024, : 1711 - 1719
  • [47] Body mass index and comorbidities are associated with the duration of COVID-19 symptoms in non-hospitalized patients
    Sarcevic, Zoran
    Tepavcevic, Andreja
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (09)
  • [48] Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score
    Sharp, Adam L.
    Huang, Brian Z.
    Broder, Benjamin
    Smith, Matthew
    Yuen, George
    Subject, Christopher
    Nau, Claudia
    Creekmur, Beth
    Tartof, Sara
    Gould, Michael K.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 46 : 489 - 494
  • [49] Anticoagulation Use as an Independent Predictor of Mortality and Major Adverse Cardiovascular Events in Hospitalized COVID-19 Patients: A Multicenter Retrospective Analysis
    DeRon, Nathan
    Hoang, Lawrence
    Aten, Kristopher
    Prathivada, Sri
    Sidhu, Manavjot
    CARDIOLOGY RESEARCH, 2023, 14 (05) : 370 - 378
  • [50] ANTICOAGULATION USE AS AN INDEPENDENT PREDICTOR OF MORTALITY AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN HOSPITALIZED COVID-19 PATIENTS: A MULTICENTER RETROSPECTIVE ANALYSIS
    DeRon, Nathan
    Hoang, Lawrence
    Sidhu, Manavjot
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (06)
12345